title: Oral posttransplantation lymphoproliferative disorder: an uncommon site for an uncommon disorder.
abstract: In 2001, the World Health Organization (WHO) published its new classification of tumors of hematopoietic and lymphoid tissues, including an entity named posttransplantation lymphoproliferative disorder (PTLD). Because oral PTLD is of clinical relevance to oral health providers, the importance of distinguishing between PTLD and nontransplantation related lymphoma is outlined, and the clinical implications of oral PTLD are discussed.
authors.affiliation: Department of Oral Medicine, Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel. eladhome@md.huji.ac.il
authors.forename: Sharon
authors.initials: S
authors.lastname: Elad
authors.forename: Cyril
authors.initials: C
authors.lastname: Meyerowitz
authors.forename: Michael Y
authors.initials: MY
authors.lastname: Shapira
authors.forename: Michael
authors.initials: M
authors.lastname: Glick
authors.forename: Menachem
authors.initials: M
authors.lastname: Bitan
authors.forename: Gail
authors.initials: G
authors.lastname: Amir
mesh_terms: D017809:Fatal Outcome; D005882:Gingival Diseases / Q000473:pathology* / Q000628:therapy / Q000821:virology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D004854:Herpesvirus 4, Human; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology*; D008232:Lymphoproliferative Disorders / Q000473:pathology* / Q000628:therapy / Q000821:virology; D008297:Male; D008875:Middle Aged; D014944:World Health Organization